Photodynamic Diagnosis and Therapy for Peritoneal Carcinomatosis from Gastrointestinal Cancers: Status, Opportunities, and Challenges

다국어 초록 (Multilingual Abstract)

Selective accumulation of a photosensitizer and the subsequent response in only the light-irradiated target are advantages of photodynamic diagnosis and therapy. The limited depth of the therapeutic effect is a positive characteristic when treating surface malignancies, such as peritoneal carcinomatosis. For photodynamic diagnosis (PDD), adjunctive use of aminolevulinic acid- protoporphyrin IX-guided fluorescence imaging detects cancer nodules, which would have been missed during assessment using white light visualization only. Furthermore, since few side effects have been reported, this has the potential to become a vital component of diagnostic laparoscopy. A variety of photosensitizers have been examined for photodynamic therapy (PDT), and treatment protocols are heterogeneous in terms of photosensitizer type and dose, photosensitizer-light time interval, and light source wavelength, dose, and dose rate. Although several studies have suggested that PDT has favorable effects in peritoneal carcinomatosis, clinical trials in more homogenous patient groups are required to identify the true benefits. In addition, major complications, such as bowel perforation and capillary leak syndrome, need to be reduced. In the long term, PDD and PDT are likely to be successful therapeutic options for patients with peritoneal carcinomatosis, with several options to optimize the photosensitizer and light delivery parameters to improve safety and efficacy.

참고문헌 (Reference)

• 1 Till H, "Videoscopic fluorescence diagnosis of peritoneal and thoracic metastases from human hepatoblastoma in nude rats" 19 : 1483-1486, 2005
• 2 Menon C, "Vascularity and uptake of photosensitizer in small human tumor nodules : implications for intraperitoneal photodynamic therapy" 7 : 3904-3911, 2001
• 3 Kishi K, "Usefulness of diagnostic laparoscopy with 5-aminolevulinic acid(ALA)-mediated photodynamic diagnosis for the detection of peritoneal micrometastasis in advanced gastric cancer after chemotherapy" 46 : 1427-1434, 2016
• 4 Goff BA, "Treatment of ovarian cancer with photodynamic therapy and immunoconjugates in a murine ovarian cancer model" 74 : 1194-1198, 1996
• 5 Tochner Z, "Treatment of murine intraperitoneal ovarian ascitic tumor with hematoporphyrin derivative and laser light" 45 : 2983-2987, 1985
• 6 Ishida M, "Trastuzumab-based photoimmunotherapy integrated with viral HER2 transduction inhibits peritoneally disseminated HER2-negative cancer" 15 : 402-411, 2016
• 7 Dedrick RL, "Theoretical and experimental bases of intraperitoneal chemotherapy" 12 : 1-6, 1985
• 8 Krogh A, "The Anatomy and Physiology of Capillaries" Yale University Press 1922
• 9 Davies N, "Tetherless fiber-coupled optical sources for extended metronomic photodynamic therapy" 4 : 184-189, 2007
• 10 Sindelar WF, "Technique of photodynamic therapy for disseminated intraperitoneal malignant neoplasms. Phase I study" 126 : 318-324, 1991
• 11 Kishi K, "Talaporfin-mediated photodynamic therapy for peritoneal metastasis of gastric cancer in an in vivo mouse model : drug distribution and efficacy studies" 36 : 313-320, 2010
• 12 Gahlen J, "Systemic vs local administration of delta-aminolevulinic acid for laparoscopic fluorescence diagnosis of malignant intra-abdominal tumors. Experimental study" 15 : 196-199, 2001
• 13 del Carmen MG, "Synergism of epidermal growth factor receptor-targeted immunotherapy with photodynamic treatment of ovarian cancer in vivo" 97 : 1516-1524, 2005
• 14 Huang Z, "Studies of a vascular-acting photosensitizer, Pd-bacteriopheophorbide(Tookad), in normal canine prostate and spontaneous canine prostate cancer" 36 : 390-397, 2005
• 15 Mroz P, "Stimulation of anti-tumor immunity by photodynamic therapy" 7 : 75-91, 2011
• 16 Kishi K, "Staging laparoscopy using ALAmediated photodynamic diagnosis improves the detection of peritoneal metastases in advanced gastric cancer" 106 : 294-298, 2012
• 17 Murayama Y, "Staging fluorescence laparoscopy for gastric cancer by using 5-aminolevulinic acid" 32 : 5421-5427, 2012
• 18 Gahlen J, "Spectrometry supports fluorescence staging laparoscopy after intraperitoneal aminolaevulinic acid lavage for gastrointestinal tumours" 52 : 131-135, 1999
• 19 Piette J, "Signalling pathway activation by photodynamic therapy : NF-κB at the crossroad between oncology and immunology" 14 : 1510-1517, 2015
• 20 Mĺkvy P, "Sensitization and photodynamic therapy(PDT)of gastrointestinal tumors with 5-aminolaevulinic acid(ALA)induced protoporphyrin IX(PPIX). A pilot study" 42 : 109-113, 1995
• 21 Yonemura Y, "Selection of patients by membrane transporter expressions for aminolevulinic acid(ALA)-guided photodynamic detection of peritoneal metastases" 4 : 66-77, 2015
• 22 Valdés PA, "Quantitative fluorescence using 5-aminolevulinic acid-induced protoporphyrin IX biomarker as a surgical adjunct in low-grade glioma surgery" 123 : 771-780, 2015
• 23 Valdés PA, "Quantitative fluorescence in intracranial tumor : implications for ALA-induced PpIX as an intraoperative biomarker" 115 : 11-17, 2011
• 24 Ascencio M, "Protoporphyrin IX fluorescence photobleaching is a useful tool to predict the response of rat ovarian cancer following hexaminolevulinate photodynamic therapy" 40 : 332-341, 2008
• 25 Ushimaru Y, "Prognostic significance of basing treatment strategy on the results of photodynamic diagnosis in advanced gastric cancer" 24 : 983-989, 2017
• 26 Bauer TW, "Preliminary report of photodynamic therapy for intraperitoneal sarcomatosis" 8 : 254-259, 2001
• 27 Beltrán Hernández I, "Preclinical and clinical evidence of immune responses triggered in oncologic photodynamic therapy : clinical recommendations" 9 : 333-, 2020
• 28 Perry RR, "Potentiation of phototherapy cytotoxicity with light scattering media" 46 : 386-390, 1989
• 29 Sato K, "Photoimmunotherapy of gastric cancer peritoneal carcinomatosis in a mouse model" 9 : e113276-, 2014
• 30 Hahn SM, "Photofrin uptake in the tumor and normal tissues of patients receiving intraperitoneal photodynamic therapy" 12 : 5464-5470, 2006
• 31 Moghissi K, "Photofrin PDT for early stage oesophageal cancer : long term results in 40 patients and literature review" 6 : 159-166, 2009
• 32 Tsujimoto H, "Photodynamic therapy using nanoparticle loaded with indocyanine green for experimental peritoneal dissemination of gastric cancer" 105 : 1626-1630, 2014
• 33 Tochner Z, "Photodynamic therapy of ascites tumours within the peritoneal cavity" 53 : 733-736, 1986
• 34 de Albuquerque IO, "Photodynamic therapy in superficial basal cell carcinoma treatment" 27 : 428-432, 2019
• 35 Herrera-Ornelas L, "Photodynamic therapy in patients with colorectal cancer" 57 : 677-684, 1986
• 36 Pinthus JH, "Photodynamic therapy for urological malignancies : past to current approaches" 175 : 1201-1207, 2006
• 37 Hillemanns P, "Photodynamic diagnosis with 5-aminolevulinic acid for intraoperative detection of peritoneal metastases of ovarian cancer : a feasibility and dose finding study" 49 : 169-176, 2017
• 38 Namikawa T, "Photodynamic diagnosis using 5-aminolevulinic acid during gastrectomy for gastric cancer" 109 : 213-217, 2014
• 39 Harada K, "Photodynamic diagnosis of peritoneal metastasis in human pancreatic cancer using 5-aminolevulinic acid during staging laparoscopy" 16 : 821-828, 2018
• 40 Lüdicke F, "Photodynamic diagnosis of ovarian cancer using hexaminolaevulinate : a preclinical study" 88 : 1780-1784, 2003
• 41 Canbay E, "Photodynamic detection and management of intraperitoneal spreading of primary peritoneal papillary serous carcinoma in a man : report of a case" 44 : 373-377, 2014
• 42 Aalders MC, "Photodetection with 5-aminolevulinic acidinduced protoporphyrin IX in the rat abdominal cavity : drug-dose-dependent fluorescence kinetics" 72 : 521-525, 2000
• 43 Ishigami H, "Phase III trial comparing intraperitoneal and intravenous paclitaxel plus S-1 versus cisplatin plus S-1 in patients with gastric cancer with peritoneal metastasis : PHOENIX-GC trial" 36 : 1922-1929, 2018
• 44 Hendren SK, "Phase II trial of debulking surgery and photodynamic therapy for disseminated intraperitoneal tumors" 8 : 65-71, 2001
• 45 Huggett MT, "Phase I/II study of verteporfin photodynamic therapy in locally advanced pancreatic cancer" 110 : 1698-1704, 2014
• 46 DeLaney TF, "Phase I study of debulking surgery and photodynamic therapy for disseminated intraperitoneal tumors" 25 : 445-457, 1993
• 47 Wilson JJ, "Patterns of recurrence in patients treated with photodynamic therapy for intraperitoneal carcinomatosis and sarcomatosis" 24 : 711-717, 2004
• 48 Swartling J, "Online dosimetry for temoporfin-mediated interstitial photodynamic therapy using the canine prostate as model" 21 : 28002-, 2016
• 49 Harada T, "Near-infrared photoimmunotherapy with galactosyl serum albumin in a model of diffuse peritoneal disseminated ovarian cancer" 7 : 79408-79416, 2016
• 50 Sato K, "Near infrared photoimmunotherapy in the treatment of disseminated peritoneal ovarian cancer" 14 : 141-150, 2015
• 51 Dakwar GR, "Nanomedicine-based intraperitoneal therapy for the treatment of peritoneal carcinomatosis-Mission possible" 108 : 13-24, 2017
• 52 Raue W, "Multimodal approach for treatment of peritoneal surface malignancies in a tumour-bearing rat model" 25 : 245-250, 2010
• 53 Bisland SK, "Metronomic photodynamic therapy as a new paradigm for photodynamic therapy : rationale and preclinical evaluation of technical feasibility for treating malignant brain tumors" 80 : 22-30, 2004
• 54 Kato A, "Maltotriose conjugation to a chlorin derivative enhances the antitumor effects of photodynamic therapy in peritoneal dissemination of pancreatic cancer" 16 : 1124-1132, 2017
• 55 Lilge L, "Light dosimetry for intraperitoneal photodynamic therapy in a murine xenograft model of human epithelial ovarian carcinoma" 68 : 281-288, 1998
• 56 Hanahan D, "Less is more, regularly : metronomic dosing of cytotoxic drugs can target tumor angiogenesis in mice" 105 : 1045-1047, 2000
• 57 Chan JK, "Laparoscopic photodynamic diagnosis of ovarian cancer using 5-aminolevulinic acid in a rat model" 87 : 64-70, 2002
• 58 Collinet P, "Laparoscopic photodynamic diagnosis of ovarian cancer peritoneal micro metastasis : an experimental study" 83 : 647-651, 2007
• 59 Gahlen J, "Laparoscopic fluorescence diagnosis for intraabdominal fluorescence targeting of peritoneal carcinosis experimental studies" 235 : 252-260, 2002
• 60 Löning M, "Laparoscopic fluorescence detection of ovarian carcinoma metastases using 5-aminolevulinic acid-induced protoporphyrin IX" 100 : 1650-1656, 2004
• 61 Yoshida K, "Is conversion therapy possible in stage IV gastric cancer : the proposal of new biological categories of classification" 19 : 329-338, 2016
• 62 Perry RR, "Intravenous vs intraperitoneal sensitizer : implications for intraperitoneal photodynamic therapy" 53 : 335-340, 1991
• 63 Molpus KL, "Intraperitoneal photoimmunotherapy of ovarian carcinoma xenografts in nude mice using charged photoimmunoconjugates" 76 : 397-404, 2000
• 64 Molpus KL, "Intraperitoneal photodynamic therapy of human epithelial ovarian carcinomatosis in a xenograft murine model" 56 : 1075-1082, 1996
• 65 Mroz P, "Intraperitoneal photodynamic therapy mediated by a fullerene in a mouse model of abdominal dissemination of colon adenocarcinoma" 7 : 965-974, 2011
• 66 Song K, "Intraperitoneal photodynamic therapy for an ovarian cancer ascite model in Fischer 344 rat using hematoporphyrin monomethyl ether" 98 : 1959-1964, 2007
• 67 Canter RJ, "Intraperitoneal photodynamic therapy causes a capillary-leak syndrome" 10 : 514-524, 2003
• 68 Harlow SP, "Intraoperative photodynamic therapy as an adjunct to surgery for recurrent rectal cancer" 2 : 228-232, 1995
• 69 Wierrani F, "Intraoperative mesotetrahydroxyphenylchlorin-based photodynamic therapy in metastatic gynecologic cancer tissue : initial results" 13 : 23-29, 1997
• 70 Shafirstein G, "Interstitial photodynamic therapy-a focused review" 9 : 12-, 2017
• 71 Lee LK, "Interstitial photodynamic therapy in the canine prostate" 80 : 898-902, 1997
• 72 Davies N, "Interstitial in vivo ALA-PpIX mediated metronomic photodynamic therapy(mPDT)using the CNS-1 astrocytoma with bioluminescence monitoring" 4 : 202-212, 2007
• 73 Theodoraki MN, "Influence of photodynamic therapy on peripheral immune cell populations and cytokine concentrations in head and neck cancer" 19 : 194-201, 2017
• 74 Zhong W, "In vivo high-resolution fluorescence microendoscopy for ovarian cancer detection and treatment monitoring" 101 : 2015-2022, 2009
• 75 Major AL, "In vivo fluorescence detection of ovarian cancer in the NuTu-19 epithelial ovarian cancer animal model using 5-aminolevulinic acid(ALA)" 66 : 122-132, 1997
• 76 Hornung R, "In vivo detection of metastatic ovarian cancer by means of 5-aminolevulinic acid-induced fluorescence in a rat model" 5 : 141-148, 1998
• 77 Wilson BC, "In vivo and post mortem measurements of the attenuation spectra of light in mammalian tissues" 42 : 153-162, 1985
• 78 Gahlen J, "Improving diagnostic staging laparoscopy using intraperitoneal lavage of delta-aminolevulinic acid(ALA)for laparoscopic fluorescence diagnosis" 126 : 469-473, 1999
• 79 Zöpf T, "Improved preoperative tumor staging by 5-aminolevulinic acid induced fluorescence laparoscopy" 62 : 763-767, 2005
• 80 Henderson BW, "How does photodynamic therapy work" 55 : 145-157, 1992
• 81 Alexander VM, "Galactosyl human serum albuminNMP1 conjugate : a near infrared(NIR)-activatable fluorescence imaging agent to detect peritoneal ovarian cancer metastases" 23 : 1671-1679, 2012
• 82 Kwon IG, "Fluorescent lymphography-guided lymphadenectomy during robotic radical gastrectomy for gastric cancer" 154 : 150-158, 2019
• 83 Kondo Y, "Fluorescent detection of peritoneal metastasis in human colorectal cancer using 5-aminolevulinic acid" 45 : 41-46, 2014
• 84 Löning MC, "Fluorescence staining of human ovarian cancer tissue following application of 5-aminolevulinic acid : fluorescence microscopy studies" 38 : 549-554, 2006
• 85 Bogaards A, "Fluorescence image-guided brain tumour resection with adjuvant metronomic photodynamic therapy : pre-clinical model and technology development" 4 : 438-442, 2005
• 86 Orth K, "Fluorescence detection of small gastrointestinal tumours : principles, technique, first clinical experience" 385 : 488-494, 2000
• 87 Piatrouskaya NA, "Experimental study of antiangiogenic and photodynamic therapies combination for treatment of peritoneal carcinomatosis : preliminary results" 32 : 100-103, 2010
• 88 Ascencio M, "Evaluation of ALA-PDT of ovarian cancer in the Fisher 344 rat tumor model" 4 : 254-260, 2007
• 89 Li Z, "Enhanced effect of photodynamic therapy in ovarian cancer using a nanoparticle drug delivery system" 47 : 1070-1076, 2015
• 90 Wong Kee Song LM, "Endoscopic detection of early upper GI cancers" 19 : 833-856, 2005
• 91 Morrison SA, "Efficacy and safety of continuous low-irradiance photodynamic therapy in the treatment of chest wall progression of breast cancer" 192 : 235-241, 2014
• 92 Kishi K, "Diagnostic laparoscopy with 5-aminolevulinic-acid-mediated photodynamic diagnosis enhances the detection of peritoneal micrometastases in advanced gastric cancer" 87 : 257-265, 2014
• 93 Liu Y, "Cytoreductive surgery under aminolevulinic acid-mediated photodynamic diagnosis plus hyperthermic intraperitoneal chemotherapy in patients with peritoneal carcinomatosis from ovarian cancer and primary peritoneal carcinoma : results of a phase I trial" 21 : 4256-4262, 2014
• 94 Garza OT, "Cytologic effects of photodynamic therapy in body fluids" 14 : 356-361, 1996
• 95 Estevez JP, "Continuous or fractionated photodynamic therapy? Comparison of three PDT schemes for ovarian peritoneal micrometastasis treatment in a rat model" 7 : 251-257, 2010
• 96 Ascencio M, "Comparison of continuous and fractionated illumination during hexaminolaevulinate-photodynamic therapy" 5 : 210-216, 2008
• 97 Regis C, "Comparison of aminolevulinic acid-and hexylester aminolevulinate-induced protoporphyrin IX fluorescence for the detection of ovarian cancer in a rat model" 25 : 304-311, 2007
• 98 Hansen RW, "Comparison of 5-aminolevulinic acid and sodium fluorescein for intraoperative tumor visualization in patients with highgrade gliomas : a single-center retrospective study" 133 : 1324-1331, 2020
• 99 Vulcan TG, "Comparison between isotropic and nonisotropic dosimetry systems during intraperitoneal photodynamic therapy" 26 : 292-301, 2000
• 100 Wierrani F, "Clinical effect of mesotetrahydroxyphenylchlorine based photodynamic therapy in recurrent carcinoma of the ovary : preliminary results" 104 : 376-378, 1997
• 101 Patel CM, "CT, MRI and PET imaging in peritoneal malignancy" 11 : 123-139, 2011
• 102 Allardice JT, "Adjuvant intraoperative photodynamic therapy for colorectal carcinoma : a clinical study" 3 : 1-10, 1994
• 103 Yokoyama Y, "A strategy using photodynamic therapy and clofibric acid to treat peritoneal dissemination of ovarian cancer" 17 : 775-779, 2016
• 104 Hahn SM, "A phase II trial of intraperitoneal photodynamic therapy for patients with peritoneal carcinomatosis and sarcomatosis" 12 : 2517-2525, 2006
• 105 Azaïs H, "A global approach for the development of photodynamic therapy of peritoneal metastases regardless of their origin" 30 : 101683-, 2020
• 106 Yan Liu, "A Pilot Randomized Clinical Study of the Additive Treatment Effect of Photodynamic Therapy in Breast Cancer Patients with Chest Wall Recurrence" 한국유방암학회 17 (17): 161-166, 2014
• 107 Canis M, "5-aminolevulinic acid-induced(ALA)fluorescence for the laparoscopic diagnosis of peritoneal metastasis. AST an experimental study" 15 : 1184-1186, 2001
• 108 Yonemura Y, "5-aminolevulinic acid fluorescence in detection of peritoneal metastases" 17 : 2271-2275, 2016
• 109 Hino H, "5-Aminolevulinic acid-mediated photodynamic therapy using light-emitting diodes of different wavelengths in a mouse model of peritoneally disseminated gastric cancer" 185 : 119-126, 2013
• 110 Fujino M, "5-Aminolevulinic acid regulates the inflammatory response and alloimmune reaction" 37 : 71-78, 2016